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Background: Trichinella spiralis is an intracellular parasite that can cause a serious threat to human health by
causing trichinellosis. The aminopeptidase (AP) was found in the proteins produced by T. spiralis infective larvae
after in vitro co-culture with intestinal epithelial cells, but its characteristics and function are unknown. The purpose
of this study was to identify the T. spiralis aminopeptidase (TsAP) and to investigate its potential as a vaccine
candidate antigen against T. spiralis infection.
Methods: T. spiralis aminopeptidase (TsAP) gene encoding a 54.7 kDa protein was cloned and expressed in
Escherichia coli, and purified recombinant TsAP protein was used to immunize BALB/c mice. The antibodies
obtained were used to determine where TsAP was localized in the parasite. Transcription and expression of TsAP in
different developmental stages of T. spiralis were observed by RT-PCR and Immunofluorescence test (IFT). The
immune protection of recombinant TsAP protein against T. spiralis infection in BALB/c mice was evaluated.
Results: Anti-TsAP antibodies recognized the native protein migrating at 54.7 kDa by Western blotting of the crude
antigens from muscle larvae. Transcription and expression of TsAP gene was observed in different developmental
stages (adult worms, newborn larvae, pre-encapsulated larvae and muscle larvae). TsAP appears to be a cytoplasmic
protein located primarily at the cuticle and internal organs of this parasite. After a challenge infection with T. spiralis
infective larvae, mice immunized with the recombinant TsAP protein displayed a 38.1% reduction in adult worm
burden and 59.1% reduction in muscle larval burden.
Conclusions: In this study, T. spiralis aminopeptidase (TsAP) was first characterized and will help reveal its potential
biological functions. TsAP is a novel potential vaccine candidate antigen that merits further investigation.
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Trichinella spiralis is an intracellular parasitic nematode
of mammalian skeletal muscles. The infective larvae in-
vade the epithelium of the small intestine, where they
mature to the adult stage, mate, and produce newborn
larvae, which enter the blood and migrate to striated
muscle where they grow and mature to the infective
stage, thus completing the life cycle [1,2]. It is well
known that the invasion of host intestinal epithelial cells* Correspondence: wangzq@zzu.edu.cn; cuij@zzu.edu.cn
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reproduction in any medium, provided the or(IECs) by the infective larvae is the first step during
T. spiralis infection. Since the larvae do not possess oral
appendices or a spike [3], it is implied that the larval
invasion of IECs may not simply be a result of mecha-
nical penetration. Some studies have shown that the
invasion of intestinal epithelia by T. spiralis can be
inhibited by antibodies against the excretory-secretory
(ES) antigens, suggesting that these ES antigens may play
an important role in the invasion and developmental
process of Trichinella larvae [4-7]. However, the mecha-
nisms by which T. spiralis infective larvae recognize,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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unknown.
Previous studies have shown that proteolytic enzymes
are present in the ES products of T. spiralis muscle larvae
(ML) [8]. Several proteases (such as serine and cysteine
proteases) have been identified to possess collagenolytic
and elastolytic activities and were inhibited by IgG mole-
cules isolated from mice infected with T. spiralis, an ob-
servation of relevance to understanding the host-parasite
interaction [9,10]. Our previous studies showed that when
the T. spiralis infective larvae were inoculated onto mono-
layers of IECs, they invade the IECs and produced several
proteins, and some of these proteins entered the IECs
[11,12]. Out of the proteins produced by the infective lar-
vae after co-culture with IECs, T. spiralis aminopeptidase
(TsAP, GenBank accession No. EFV57052) was identified
by shotgun LC-MS/MS. TsAP is a kind of proteolytic
enzyme, it can catalyze the amino acid release from the
N-terminus of a polypeptide chain and plays an important
role in the degradation of some bioactive peptides [13].
TsAP might be related with the larval invasion of IECs
and mediate or facilitate the entry into cells.
In the present study, the TsAP gene encoding a
54.7 kDa protein from T. spiralis muscle larvae was
cloned and identified. The expression, immunoloca-
lization of TsAP and the immune protection conferred
by the recombinant TsAP protein was also investigated.
Methods
Parasites and experimental animals
The isolate (ISS534) of T. spiralis used in this study was
obtained from domestic pigs in Nanyang, Henan Province,
China. The Trichinella isolate was maintained by serial
passage in Kunming mice every 6–8 months. Specific
pathogen-free (SPF) male BALB/c mice aged 5 weeks were
purchased from the Experimental Animal Center of
Henan Province and used for the immunological studies
and challenge infection.
Collection of worms and preparation of crude and ES
antigens
T. spiralis muscle larvae (ML) from infected mice at
42 days post-infection (dpi) were recovered by digestion
of carcasses with 0.33% pepsin (1:31000; Sigma) and 1%
HCl [14]. The pre-encapsulated larvae (PEL) at 19 dpi
were isolated using Baermann’s method [15]. Adult
worms (AW) were isolated from the small intestines of
infected mice at 3 dpi [16]. The newborn larvae (NBL)
were collected from female adult worms and cultured in
RPMI-1640 medium containing 10% fetal bovine serum
(FBS; Gibco) in 5% CO2 at 37°C for 24 h [17].
The crude and ES antigens of the ML were prepared
as previously described [11]. In brief, after washing
thoroughly in sterile saline, the larvae were again washedfour times in serum-free RPMI-1640 medium sup-
plemented with 100 U penicillin/ml and 100 μg strep-
tomycin/ml. The larvae were incubated in the same
medium at a concentration of 5000 worms/ml for 18 h at
37°C in 5% CO2. After incubation, the media containing
the ES products were filtered through a 0.2 μm membrane
into a 50 ml conical tube, then centrifuged at 4°C,
15,000 × g for 30 min. The supernatant was dialyzed
against deionized water at 4°C for 2 days, and then con-
centrated by a vacuum concentration and freeze drying
(Heto Mxi-Dry-Lyo, Denmark), respectively. The protein
concentration of ES antigens (1.26 mg/ml) was deter-
mined by the method described by Bradford [18].
Cloning, expression, and identification of TsAP
Total RNA was extracted from the ML using Trizol
(Invitrogen). The first-strand synthesis of cDNA was
accomplished using AMV reverse transcriptase (Promega,
USA) and oligo (dT) primers at 42°C for 1 h according to
the manufacturer’s instructions. The TsAP gene was amp-
lified by PCR, and specific primers carrying BamHI and
XhoI restriction enzyme sites (Forward, 5′-ATAGGATC
CATGAGCCGCAAAGGATTGATG-3′; Reverse, 5′-CCG
CTC GAGTCAACTAGATTTTGCCAAAAG-3′) were
used. The cycling protocol was as follows: 30 cycles of
94°C for 45 s, 58°C for 45 s and 72°C for 1.5 min. The
purified PCR products were cloned into the expression
vector pGEX-6p-1 (Novagen, USA) using the BamHI and
XhoI sites. The recombinant plasmid was then trans-
formed into Escherichia coli BL21 (Novagen, USA). The
expression of the recombinant protein was induced with
0.5 mM IPTG at 37°C for 4 h, with the formation of inso-
luble inclusion bodies. The inclusion bodies were reco-
vered from the bacterial lysates by centrifugation at
12,000 g for 10 min and dissolved in 8 M urea. After
denaturing in urea, gradient dialysis was used for protein
renaturation. Then the refolded proteins were purified
by Glutathione Sefinose resin (Bio Basic Inc, Canada).
The purified recombinant proteins were analyzed by so-
dium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS–PAGE) using a 5% acrylamide stacking gel and
12% acrylamide separating gel (83 × 73 × 1.0 mm) with a
Mini-PROTEAN 3 Cell electrophoresis unit (BioRad,
USA) at 120 V for 2.5 h [11]. After electrophoresis, the
gel was stained with 0.25% Coomassie brilliant blue R-
250 for 4 h and then destained (10% acetic acid and 5%
ethanol). Another gel was prepared in the same way and
used for the immunoblotting described below.
Generation of antibodies to recombinant TsAP protein, ES
and surface antigens
A total of 20 male BALB/c mice were divided into
two groups of 10 mice each. Pre-immune sera were
collected by tail bleeding 2 days prior to the first
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immunized with 20 μg of recombinant TsAP proteins
or ES antigens, followed by three boosts with the
same amount of protein at 10-day intervals. Seven
days after the last boost, the mice were bled, and the
sera were collected.
Antibody determination
The specific IgG antibodies to TsAP in serum of
immunized mice were determined by ELISA using
corresponding recombinant, ES or crude antigens.
The procedure was performed as previously described
[19]. Briefly, microtiter plates (Nunc) were coated
with recombinant TsAP proteins, ES or crude anti-
gens (2.5 μg/ml) in coating buffer overnight at 4°C,
and blocked with 200 μl of PBS-0.1% Tween 20
(PBST) containing 5% skimmed milk. Then, 100 μl of
immune serum samples with 1:100 dilution in PBS
were added to each well and incubated at 37°C for
1 h. HRP-conjugated goat anti-mouse IgG antibodies
(1:5000; Southern Biotechnology, USA) were added
and incubated for 1 h at 37°C. The plates were deve-
loped with o-phenylenediamine dihydrochloride sub-
strate (OPD; Sigma), and the absorbance was
measured at 490 nm.
Western blot analysis
Samples including crude antigens, ES antigens and the
recombinant proteins were separated by SDS–PAGE
and then transferred onto nitrocellulose membranes
(Millipore, USA) using a trans-blot SD transfer cell
(Bio-Rad, USA) [20]. The membranes were cut into
strips, blocked with 5% skimmed milk in Tris-Buffered
Saline with Tween-20 (TBST) at 37°C for 1 h, and incu-
bated at 37°C for 1 h with 1:100 dilution of different
mouse sera (anti-TsAP serum, serum from mice infected
T. spiralis at 30 dpi and normal mouse serum). After
washing, the strips were incubated at 37°C for 1 h with
HRP-conjugated goat anti-mouse IgG (1:5000 dilution;
Southern Biotechnology, USA), and finally with 3, 3’-
diaminobenzidine tetrahydrochloride (DAB; Sigma).
RT-PCR analysis of TsAP gene transcription
To observe the transcription of the TsAP gene at dif-
ferent developmental stages of T. spiralis, total RNA
was extracted from the ML at 42 dpi, PEL at 18 dpi,
AW at 3 dpi and NBL of T. spiralis. RT-PCR was
performed as previously described [21]. The house-
keeping gene GAPDH (glyceraldehyde-3-phosphate
dehydrogenase, GenBank accession No. AF452239) of
Trichinella was used as a constitutively expressed
standard gene. The primers were designed as follows:
forward, 5′-TTAATGTCGTGGCTGTGAAT-3′, and
reverse, 5′-CCAGTAGAAG CAGGGATGAT-3′.Immunofluorescence test (IFT)
IFT was used to observe the expression of TsAP at dif-
ferent developmental stages and its immunolocalization
in the parasite. The skeletal muscles from mice infected
with T. spiralis were collected at 19 and 42 dpi, respec-
tively, and were fixed in 4% paraformaldehyde and em-
bedded in paraffin. Microtome-cut 4-μm sections were
placed on slides, deparaffinized in xylene and re-
hydrated. The whole parasites and tissue sections were
blocked with 5% normal goat serum in PBS and then in-
cubated in a moist chamber at 37°C for 1 h with a 1:10
dilution of immune and normal sera. After washing
three times in PBS, the whole parasites and sections
were incubated with a 1:50 dilution of FITC-labeled
goat anti-mouse IgG (Santa Cruz, USA), washed five
times in PBS, and examined under a fluorescent micro-
scope (Olympus, Japan) [11].
Immune protection against challenge infection
To determine the immune protection of the recom-
binant TsAP protein, a total of 48 male BALB/c mice
were divided into three groups (immune group, adjuvant
control group and PBS control group) of 16 mice each.
Pre-immune sera were collected by tail bleeding 2 days
prior to the first immunization. The immune groups of
BALB/c mice were subcutaneously immunized with
20 μg of purified recombinant TsAP protein. The vac-
cines were prepared at a 1:1 ratio by mixing each antigen
in Freund’s complete adjuvant for the first immunization
or Freund’s incomplete adjuvant for the subsequent
immunizations (three boosts at 10 day- intervals) and
administered intraperitoneally and intradermally at mul-
tiple sites of the abdomen. The control group received
PBS with the corresponding adjuvant or PBS only. Ten
days after the last immunization, all the three groups of
mice were orally challenged with 300 T. spiralis muscle
larvae. Eight mice from each group were euthanized
3 days after challenge and the numbers of intestinal
adult worms were counted [22]. The muscle larvae were
examined from another 8 mice from each group 42 days
after challenge by artificial digestion of all the whole
carcass of each infected mouse [14]. The protective
immunity was calculated as the worm reduction rate of
recovered adults and larvae per gram (LPG) muscle from
the immunized groups versus those from the control
groups [19].
Statistical analysis
All of the statistical analyses of the data were per-
formed using SPSS for Windows, version 17.0 (SPSS
Inc., Chicago, IL). The AW and ML recovery data were
expressed as the mean value ± standard deviation (SD),
and the differences among the groups were analyzed
using the one-way ANOVA method. When a pairwise
Figure 1 Identification of recombinant TsAP protein.
(A) SDS-PAGE analysis of recombinant TsAP protein. M: protein
molecular weight marker; 1: the lysis of the induced recombinant
bacteria after ultrasonication; 2: TsAP inclusion body dissolved in 8 M
urea; 3: recombinant TsAP protein purified by GST Sefinose Resin.
(B) Western-blot analysis of recombinant TsAP protein antigenicity.
The T. spiralis crude antigens (lane 1), ES antigens (lane 2), and
recombinant TsAP protein (lane 3) were recognized by sera of mice
infected with T. spiralis at 30 dpi. The native TsAP protein in crude
antigens (lane 4) and recombinant TsAP protein (lane 6) were
recognized by anti-TsAP serum, but the ES antigens (lane 5) were
not recognized by anti-TsAP serum. The T. spiralis crude antigens
(lane 7), ES antigens (lane 8), and recombinant TsAP protein (lane 9)
were not recognized by sera of normal mice.
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cant test was used. The statistical significance was
defined as P < 0.05.
Results
Molecular cloning and expression of a cDNA encoding
TsAP
The cDNA sequence of TsAP gene is 1515 bp. The
Blast analysis showed that the TsAP gene cloned in
this study was 97% identical to the sequence of TsAP
gene in GenBank. The full coding sequence of TsAP
gene was cloned into the prokaryotic expression plas-
mid pGEX-6p-1. After induction with 1 mM IPTG,
BL21 bacteria harboring pGEX-6p-1-TsAP expressed a
80.7 kDa fusion protein. Using SDS-PAGE, the
molecular size of the recombinant protein was con-
sistent with the predicted combined size of the poly-
peptide encoded by the cDNA clone (54.7 kDa) and
N-terminal GST tag from the vector (26 kDa)
(Figure 1A).
Western blot and ELISA analysis of the recombinant TsAP
protein
The Western blot analysis showed that the recombi-
nant TsAP protein was recognized by an anti-TsAP
serum and serum of mice infected T. spiralis. The
54.7 kDa protein component of the crude antigens of
T. spiralis ML were recognized by the anti-TsAP
serum (Figure 1B). The results of the ELISA showed
that anti-TsAP serum recognized the recombinant
TsAP protein and crude antigens, but did not
recognize the ES antigens (Figure 2). The results indi-
cated that TsAP is one component of the crude anti-
gens but not from ES antigens.Figure 2 The specific IgG antibody levels of mice immunized
with recombinant TsAP protein assayed by ELISA using
different antigens. The optical density (OD) values shown for each
group are the mean ± standard deviation (SD) of antibody levels
(n = 13). Asterisks (*) indicate statistically significant differences
(P < 0.01) in OD values of one kind of antigens compared to other
two kinds of antigens.
Figure 3 RT-PCR analysis of TsAP gene transcript at different
stages of T. spiralis. RT-PCR detection of mRNA transcription for
the TsAP gene (A) and GAPDH gene (B) at different developmental
stages of T. spiralis. M: DNA marker; Lane 1: AW at 3 dpi; Lane 2: ML
at 42 dpi; Lane 3: PEL at 19 dpi; Lanes 4: NBL.
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The transcript of the TsAP gene at different develop-
mental stages of T.spiralis was determined using RT-
PCR with the transcript of housekeeping gene GAPDH
as a control. The mRNA transcript (1515 bp) for the
TsAP gene was detected at all of the developmental
stages (e.g., AW at 3 dpi, NBL, PEL at 19 dpi and ML at
42 dpi) (Figure 3A). Furthermore, the primers for a
standard gene (GAPDH) generated the expected size
(570 bp) band in all of the samples (Figure 3B).
Expression of TsAP at different developmental stages and
immunolocalization
The results of IFT with the whole parasite showed that
the intense staining using anti-TsAP serum was found in
the body of all the different developmental stages of
T. spiralis (e.g., AW at 3 dpi, NBL, PEL at 19 dpi and
ML at 42 dpi) (Figure 4). When the sections of skeletal
muscle tissues of infected mice were incubated with the
anti-TsAP serum, positive staining was found at the
cuticle and internal organs of PEL at 19 dpi and ML at
42 dpi (Figure 4).
Immune protection of recombinant TsAP against
challenge infection
Protective immunity against T. spiralis infection induced
by the recombinant TsAP protein was observed in im-
munized BALB/c mice. After the challenge infection
with T. spiralis infective larvae, the mice immunized
with the recombinant TsAP protein displayed a 38.1%
reduction in their adult worm burden (Figure 5A) and
59.1% reduction in the muscle larval burden (Figure 5B)
compared with the groups immunized with adjuvant or
PBS alone; these differences were statistically significant
(Fadults =47.38, Flarvae =64.23, P < 0.05).
Discussion
In the present study, the TsAP gene encoding a 54.7 kDa
protein from T. spiralis was successfully cloned and
expressed in an E. coli expression system, and the
resulting recombinant protein and immune serum were
used to define some characteristics of the native
54.7 kDa protein of T. spiralis. The expression at high
levels of a foreign protein in E. coli results in the forma-
tion of inclusion bodies composed of insoluble inactive
aggregates of the expressed protein; however, after puri-
fication, such recombinant protein has a good immuno-
genicity in mice and can be used as an immunogen to
Figure 4 Expression of TsAP at different developmental stages and immunolocalization in T. spiralis. A–H: The results of IFT with whole
parasite of T. spiralis different stages reacted with anti-TsAP serum. The notable immunostaining is found in the body of AW at 3 dpi (A), NBL
(B), PEL at 19 dpi (C) and ML at 42 dpi (D). The ML at 42 dpi reacted with serum of mice infected T. spiralis at 30 dpi (E) as a positive control; ML
at 42 dpi did not show recognition by normal serum (F) as a negative control. G–L: The results of IFT with the sections of skeletal muscles of
infected mice reacted with anti-TsAP serum. The immunostaining is seen at the cuticle and internal organs of PEL at 19 dpi (G) and ML at 42 dpi
(H and I). The ML at 42 dpi reacted with anti-ES serum (J) and serum of mice infected T. spiralis at 30 dpi (K) as a positive control, ML at 42 dpi
did not did not show recognition by normal mouse serum (L) as a negative control.
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immunized directly with the purified recombinant TsAP
protein produced strong specific antibodies against the
recombinant TsAP protein. Our Western blot analysis
showed that the anti-TsAP serum obviously recognized
the 54.7 kDa band in the crude antigens of T. spiralis
muscle larvae. The results of the ELISA also indicated
that the crude antigens strongly reacted with anti-TsAP
serum, but the ES antigens were not recognized by anti-
TsAP serum. Our results demonstrated that the TsAPprotein might be one of components of the somatic anti-
gens of T. spiralis ML.
The characteristics of TsAP were identified at the gene
transcription and protein expression levels using RT-
PCR and IFT. As shown in Figure 3, the results of RT-
PCR showed that the TsAP mRNA is transcribed during
all the different developmental stages of T. spiralis (AW,
ML, NBL and PEL). The IFT revealed positive stainings
were widely distributed in the body of the whole para-
sites (AW, ML, NBL and PEL) or sections of infected
Figure 5 The number of adult worms (A) and larvae per gram
(lpg) muscles (B) recovered from vaccinated mice after a
challenge infection with 300 T. spiralis larvae. Results are
presented as the arithmetic mean ± standard deviation (SD) of eight
mice in each group. Asterisks (*) indicate statistically significant
differences (P < 0.01) in worm recovery of the immunized group
compared to both control groups.
Zhang et al. Parasites & Vectors 2013, 6:246 Page 7 of 8
http://www.parasitesandvectors.com/content/6/1/246muscles incubated with the anti-TsAP serum. Amino-
peptidases are exopeptidases that catalyze the sequential
removal of amino acids from the N termini of peptides
and play a major role in regulating the balance between
catabolism and anabolism in all living cells [13]. The
aminopeptidases belong to Peptidase M17 family, which
can also be classified into different aminopeptidases
according to its major substrate. Leucine aminopep-
tidases (LAP) are the representative group of aminopep-
tidases [13]. They have been identified, purified and
characterized in many helminth and protozoal parasites
[23,24] and shown to play important roles such as
molting, surface membrane remodeling, egg hatching
and digestion for the survival of parasites within host
[25-27]. The tissue localization and functional analysis of
LAP in Setaria cervi and several other nematodes also
suggested that this enzyme is involved in parasite fee-
ding, final digestion of the partially hydrolysed peptide
fragments within gastrodermal cells, cuticle remodeling,
egg hatching and embryogenesis [28,29]. However, to
the best of our knowledge, there has been no report of
the characterization and functional analysis of TsAP.The protein sequences of TsAP were compared with the
protein database by the search protein database (http://
blast.ncbi.nlm.nih.gov/). The results showed that the
TsAP protein is one of the number of cytoplasmic ami-
nopeptidase families, distributed in the cytoplasm, and
might play an important role in the larval invasion and
development of T. spiralis.
Our results showed that TsAP gene was transcribed
and expressed during all the different developmental
stages of T. spiralis, suggesting that the TsAP is an indis-
pensable protein and plays an important role in the life
cycle of T. spiralis. Furthermore, after the challenge
infection with T. spiralis infective larvae, the mice im-
munized with the recombinant TsAP protein displayed a
38.1% reduction in adult worm burden and a 59% reduc-
tion in muscle larval burden. The ML reduction ob-
served in this study is higher than previously reported
[19,21,30,31], which might be related to the different
expression vectors used. In the present study, the re-
combinant TsAP protein carried GST-tag, which might
have antigenicity and increase the immune protection.
Additionally, attenuated Salmonella strains are especially
attractive live vectors because they elicit mucosal im-
munity, which is known to be important for the control
of T. spiralis infection during the intestinal stage and
can be administered by oral or intranasal routes. The
mice immunized by intranasal route with the recom-
binant Salmonella carrying a T. spiralis gp43 antigen-
derived 30-mer epitope elicited a protective immune
response against challenge infection, reducing by 61.83%
the adult burden at 8 dpi [32]. Other study showed that
the vaccination with only LAP purified from Fasciola
hepatica adults induced high levels of protection (89%)
against fascioliasis in sheep [33]. The results showed that
the recombinant TsAP protein induced a partial pro-
tective immunity in mice and could be considered as a
novel potential vaccine candidate antigen against T.
spiralis infection.Conclusions
For the first time, we have presented the molecular
characterization of the aminopeptidase from T. spiralis.
The TsAP gene was transcribed and expressed during all
the different developmental stages of T. spiralis, sug-
gesting that the TsAP is an indispensable protein and
plays an important role in the life cycle of T. spiralis.
TsAP appears to be a cytoplasm protein located pri-
marily at the cuticle and internal organs of this parasite.
The results of this study show that mice vaccinated with
the recombinant TsAP protein could induce partial
protective immunity against T. spiralis infection, indi-
cating TsAP might be a novel potential vaccine candi-
date antigen.
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